Given the benefits of technology use in youth with depression, clinicians who continue to be hesitant to prescribe a pump to due to fears of “suicide by insulin” should consider using tailored screening of suicide risk rather than a broader depression or mood measure. This evidence concerns the gene INS and major depressive disorder.